Two lawmakers are asking the U.S. Department of Justice (DOJ) to open a criminal investigation to determine if the New England Compounding Center (NECC) violated any state or federal laws, directly contributing to the contamination of steroid products that were distributed to more than 20 states.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.